May 31, 2020
Innovent Biologics and Lilly Jointly Announced the Pivotal Clinical Study Results of TYVYT® (Sintilimab Injection) in the Second-Line Treatment of Patients with Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
May 11, 2020
VIVA Physicians Publishes Analysis Evaluating Mortality and Paclitaxel-Coated Devices
Apr 23, 2020
Leap Therapeutics to Present Updated Data for DKN-01 Monotherapy and Paclitaxel Combination In Gynecologic Cancers
Mar 25, 2020
Elevar Therapeutics Acquires Global Rights to European Approved Apealea® from Oasmia Pharmaceutical
Jan 13, 2020
Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab
Nov 05, 2019
First Round of Late-Breaking Clinical Trial Results Announced at VIVA19
Nov 05, 2019
Boston Scientific Announces Positive Data for the Ranger(TM) Drug-Coated Balloon and the Eluvia(TM) Drug-Eluting Vascular Stent at VIVA19
Oct 30, 2019
Breast Cancer Awareness Month Arrives With New Teamwork From Biotech Developers on the Way
Oct 22, 2019
Global Bulk Paclitaxel Industry
Sep 28, 2019
BD Announces Publication of an Independent Analysis of Drug-Coated Balloon Safety Data for Femoropopliteal Peripheral Arterial Disease
Jul 01, 2019
Boston Biomedical, Inc. Announces Update on Phase 3 CanStem111P Study of Napabucasin in Patients with Metastatic Pancreatic Cancer Following Interim Analysis
Jun 24, 2019
Update on FDA Panel Meeting on Paclitaxel Coated Products
May 22, 2019
United States $20 Bn Breast Cancer Drug Market to 2025: 42 Marketed Drugs, 317 Drugs in Clinical Pipeline by Company, Phase, Drug Class & Patient Segment
Mar 20, 2019
Xynomic Pharmaceuticals, Inc. Will Present at ASCO 2019 Annual Meeting, Will Sponsor an EU Investigator Meeting for Potentially Pivotal Kidney Cancer Trial, and Appoints Interim Chief Accounting Officer
Mar 09, 2019
VIVA Physicians Selects NAMSA as Statistical Analytic Group to Evaluate the Safety of Paclitaxel Drug-Eluting Technologies in PAD
Jan 21, 2019
VIVA Physicians to Lead Pan-Industry Collaboration to Further Evaluate the Use of Paclitaxel Drug-Eluting Technologies in PAD
Jan 18, 2019
AbbVie Provides Update on Phase 3 Study of Ibrutinib (IMBRUVICA®) in Metastatic Pancreatic Cancer
Jan 03, 2019
Agenus Awarded Grant to Enable QS-21 Innovations
Sep 24, 2018
Boston Scientific Receives U.S. FDA Approval for the Eluvia(TM) Drug-Eluting Vascular Stent System
Sep 22, 2018
Boston Scientific Eluvia Drug-Eluting Stent Demonstrates Superior Results In IMPERIAL Trial